Findings
amnestic, MCI, dementia, cognitive impairment
BLOOD, SECONDARY
In this secondary analysis of 7918 participants in the Systolic Blood Pressure Intervention Trial with a median follow-up of 4 years, participants with higher baseline risk of probable dementia or amnestic mild cognitive impairment (MCI) gained greater absolute cognitive benefit from intensive vs standard SBP treatment.